Cytokine transport across the injured blood-spinal cord barrier

Current Pharmaceutical Design

Volumn 14, Issue 16, 2008, Pages 1620-1624

  Pan, Weihong ^a   Kastin, Abba J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Blood brain barrier; Cytokines; LIF; Neurotrophins; Spinal cord injury; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 15; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; BLOOD BRAIN BARRIER; BLOOD SPINAL CORD BARRIER; MEMBRANE TRANSPORT; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL PLASTICITY; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; TRANSCRIPTION REGULATION; TRAUMATIC BRAIN INJURY; UPREGULATION;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; PROTEIN TRANSPORT; SPINAL CORD; SPINAL CORD INJURIES; UP-REGULATION;

EID: 48949117574     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208784705450     Document Type: Review

References (53)

1. Brightman MW, Klatzo I, Olsson Y, Reese TS. The blood-brain barrier to proteins under normal and pathological conditions. J Neurol Sci 1970; 10: 215-39.
2. Sharma HS. In: Sharma HS, Westman J Eds, Blood-spinal cord and brain barriers in health and disease; Elsevier San Diego, CA, 2004; 437-518.
3. Bilgen M, Dogan B, Narayana PA. In vivo assessment of blood-spinal cord barrier permeability: Serial dynamic contrast enhanced MRI of spinal cord injury. Magn Reson Imaging 2002; 20: 337-41.
4. Noble LJ, Wrathall JR. Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res 1989; 482: 57-66.
5. Ding Y, Kastin AJ, Pan W. Neural plasticity after spinal cord injury. Curr Pharm Des 2005; 11: 1441-50.
6. Xiang S, Pan W, Kastin AJ. Strategies to create a regenerating environment for the injured spinal cord. Curr Pharm Des 2005; 11: 1267-77.
7. Kastin AJ, Pan W. Targeting neurite growth inhibitors to induce CNS regeneration. Curr Pharm Des 2005; 11: 1247-53.
8. Wang CX, Nuttin B, Heremans H, Dom R, Gybels J. Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J Neuroimmunol 1996; 69: 151-6.
9. Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993; 47: 169-76.
10. Pan W, Banks WA, Kastin AJ. Permeability of the blood-brain and blood-spinal cord barriers to interferons. J Neuroimmunol 1997; 76: 105-11.
11. Pan W, Kastin AJ. TNFα transport across the blood-brain barrier is abolished in receptor knockout mice. Exp Neurol 2002; 174: 193-200.
12. Pan W, Csernus B, Kastin AJ. Upregulation of p55 and p75 receptors mediating TNF alpha transport across the injured blood-spinal cord barrier. J Mol Neurosci 2003; 21: 173-84.
13. Pan W, Kastin AJ, Daniel J, Yu C, Baryshnikova LM, von Bartheld CS. TNF alpha trafficking in cerebral vascular endothelial cells. J Neuroimmunol 2007; 185: 47-56.
14. Pan W, Tu H, Yu C, Hsuchou H, Yang Y, Kastin AJ. Differential role of TNF receptors in cellular tafficking of intact TNF. Cell Phyiosiol Biochem 2007; 20: 559-68.
15. Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA, Kastin AJ: Tumor necrosis factor-α: A neuromodulator in the CNS. Neurosci Biobehav Rev 1997; 21: 603-13.
16. Schwartz M, Solomon A, Lavie V, Ben-Bassat S, Belkin M, Cohen A. Tumor necrosis factor facilitates regeneration of injured central nervous system axons. Brain Res 1991; 545: 334-8.
17. Schwartz M, Sivron T, Eitan S, Hirschberg DL, Lotan M, Elman-Faber A. Cytokines and cytokine-related substances regulating glial cell response to injury of the central nervous system. Prog Brain Res 1994; 103: 331-41.
18. Hirschberg DL, Yoles E, Belkin M, Schwartz M. Inflammation after axonal injury has conflicting consequences for recovery of function: Rescue of spared axons impaired but regeneration is supported. J Neuroimmunol 1994; 50: 9-16.
19. Klusman I, Schwab ME. Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res 1997; 762: 173-84.
20. Kim DH, Gutin PH, Noble LJ. Treatment with genetically engineered fibroblasts producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat. Neuroreport 1996; 7: 2221-5.
21. Pan W, Banks WA, Kastin AJ. Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury. Exp Neurol 1997; 146: 367-73.
22. Pan W, Kastin AJ, Bell RL, Olson RD. Upreguladon of tumor necrosis factor α transport across the blood-brain barrier after acute compressive spinal cord injury. J Neurosci 1999; 19: 3649-55.
23. Pan W, Kastin AJ. Increase in TNFα transport after SCI is specific for time, region and type of lesion. Exp Neurol 2001; 170: 357-63.
24. Pan W, Zhang L, Liao J, Csernus B, Kastin AJ. Selective increase in TNFα permeation across the blood-spinal cord barrier after SCI. J Neuroimmunol 2003; 134: 111-7.
25. Pan W, Kastin AJ. Upregulation of the transport system for TNFα at the blood-brain barrier. Arch Physiol Biochem 2001; 109: 350-3.
26. Pan W, Kastin AJ. TNFα transport across the blood-brain barrier is abolished in receptor knockout mice. Exp Neurol 2002; 174: 193-200.
27. Pan W, Banks WA, Kennedy MK, Gutierrez EG, Kastin AJ. Differential permeability of the BBB in acute EAE: Enhanced transport of TNF-α. Am J Physiol 1996; 34: E636-42.
28. Pan W, Hsuchou H, Yu C, Kastin AJ. Permeation of blood-borne IL15 across the blood-brain barrier and the of effect of LPS. J Neurochem (in press). PMID No. 18384647.
29. Pan W, Kastin AJ, Rigai T, McLay RN, Pick CG. Increased hippocampal uptake of tumor necrosis factor α and behavioral changes in mice. Exp Brain Res 2003; 149: 195-9.
30. Pan W, Ding Y, Yu Y, Ohtaki H, Nakamachi T, Kastin AJ. Stroke upregulates TNFα transport across the blood-brain barrier. Exp Neurol 2006; 198: 222-33.
31. Pan W, Kastin AJ, Brennan JM. Saturable entry of leukemia inhibitory factor from blood to the central nervous system. J Neurochem 2000; 106: 172-80.
32. Pan W, Kastin AJ, Maness LM, Brennan JM. Saturable entry of ciliary neurotrophic factor into brain. Neurosci Lett 1999; 263: 69-71.
33. Pan W, Cain CM, Yu Y, Kastin AJ. Receptor-mediated transport of LIF across blood-spinal cord barrier is upregulated after spinal cord injury. J Neuroimmunol 2006; 174: 119-25.
34. Yu C, Kastin AJ, Tu H, Pan W. Opposing effects of proteasomes and lysosomes on LIFR: Modulation by TNF. J Mol Neurosci 2007; 32: 80-9.
35. Yu C, Kastin AJ, Pan W. TNF reduces LIF endocytosis despite increasing NFkappaB-mediated gp130 expression. J Cell Physiol 2007; 213: 161-6.
36. Kastin AJ, Akerstrom V, Pan W. Activation of urocortin transport into brain by leptin. Peptides 2000; 21: 1811-7.
37. Kastin AJ, Pan W, Akerstrom V, Hackler L, Wang C, Kotz CM. Novel peptide-peptide cooperation may transform feeding behavior. Peptides 2002; 23: 2189-96.
38. Kastin AJ, Pan W. Feeding peptides interact in several ways with the blood-brain barrier. Curr Pharm Des 2003; 9: 789-94.
39. Pan W, Akerstrom V, Zhang J, Pejovic V, Kastin AJ. Modulation of feeding-related peptide/protein signals by the blood-brain barrier. J Neurochem 2004; 90: 455-61.
40. Pan W, Kastin AJ. Adipokines and the blood-brain barrier. Peptides 2007; 28: 1317-30.
41. Pan W, Cain C, Yu Y, Kastin AJ. Receptor-mediated transport of LIF across blood-spinal cord barrier is upregulated after spinal cord injury. J Neuroimmunol 2006; 174: 119-25.
42. Pan W, Yu C, Hsuchou H, Zhang Y, Kastin AJ. Neuroinflammation facilitates LlF entry into brain: Role of TNF. Am J Physiol (in press).
43. Kastin AJ, Akerstrom V, Pan W. Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: Meaningful controls. Peptides 2001; 22: 2127-36.
44. Pan W, Kastin AJ. In: Sharma HS, Westman J, Eds, Blood-spinal cord and brain barriers in health and disease; Elsevier. San Diego, CA, 2004; 395-407.
45. Pan W, Kastin AJ, Gera L, Stewart JM. Bradykinin antagonist decreases early disruption of the blood-spinal cord barrier after spinal cord injury in mice. Neurosci Lett 2001; 307: 25-8.
46. Banks WA, Kastin AJ, Arimura A. Effect of spinal cord injury on the permeability of the blood-brain and blood-spinal cord barriers to the neurotrophin PACAP. Exp Neurol 1998; 151: 116-23.
47. Banks WA, Kastin AJ, Ehrensing Cg Blood-borne interleukin-1α is transported across the endothelial blood-spinal cord barrier of mice. J Physiol 1994; 479(Pt 2): 257-64.
48. McLay RN, Kimura M, Banks WA, Kastin AJ. Granulocyte-macrophage colony-stimulating factor crosses the blood-brain and blood-spinal cord barriers. Brain 1997; 120: 2083-91.
49. Kastin AJ, Akerstrom V, Pan W. Neuregulin-1-beta1 enters brain and spinal cord by receptor-mediated transport. J Neurochem 2004; 88: 965-70.
50. Pan W, Banks WA, Kastin AJ. Permeability of the blood-brain/spinal cord barrier to neurotrophins. Brain Res 1998; 788: 87-94.
51. Mocellin S, Pilati P, Nitti D. Towards the development of tumor necrosis factor (TNF) sensitizers: Making TNF work against cancer. Curr Pharm Des 2007; 13(5): 537-51.
52. Sharma HS. Neurotrophic factors in combination: A possible new therapeutic strategy to influence pathophysiology of spinal cord injury and repair mechanisms. Curr Pharm Des 2007; 13(18): 1841-74.
53. Sharma HS, Sjoquist PO, Ali SF. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: Neuroprotective effects of a new antioxidant compound H-290/51. Curr Pharm Des 2007; 13(18): 1903-23.